Livent Stock (NYSE:LTHM)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$18.05

52W Range

$5.20 - $17.51

50D Avg

$6.32

200D Avg

$8.51

Market Cap

$2.97B

Avg Vol (3M)

$20.42M

Beta

1.76

Div Yield

-

LTHM Company Profile


Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications. It also provides lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride, and specialty organics; and lithium carbonate and lithium chloride for use as feedstock in the process of producing performance lithium compounds. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.

Show More

Industry

Chemicals - Specialty

Sector

Basic Materials

Exchange

NYSE

ADR

-

Country

US

Employees

1,350

IPO Date

Oct 11, 2018

Website

LTHM Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 22Dec 21Dec 20
Butyllithium$277.70M$105.40M$87.10M
Lithium Carbonate & Lithium Chloride$69.10M$70.10M$11.90M
High Purity Lithium Metal and Other Specialty Compounds$50.90M$36.90M$31.70M
Lithium Hydroxide$415.50M$208.00M$157.50M

Fiscal year ends in Dec 22 | Currency in USD

LTHM Financial Summary


Dec 22Dec 21Dec 20
Revenue$813.20M$420.40M$288.20M
Operating Income$316.00M$2.90M$-35.90M
Net Income$273.50M$600.00K$-18.90M
EBITDA$343.70M$28.00M$-10.90M
Basic EPS$1.59-$-0.13
Diluted EPS$1.36-$-0.13

Fiscal year ends in Dec 22 | Currency in USD

Latest Earnings Call Transcripts


Q3 23Oct 31, 23 | 7:25 PM
Q2 23Aug 03, 23 | 8:06 PM
Q1 23May 02, 23 | 9:28 PM

Peer Comparison


TickerCompany
DDDuPont de Nemours, Inc.
PPGPPG Industries, Inc.
ALTOAlto Ingredients, Inc.
ECLEcolab Inc.
DNMRDanimer Scientific, Inc.
SHWThe Sherwin-Williams Company
ALBAlbemarle Corporation
SQMSociedad Química y Minera de Chile S.A.
LINLinde plc
APDAir Products and Chemicals, Inc.
AMRSAmyris, Inc.
LYBLyondellBasell Industries N.V.